PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Clinical/translational cancer immunotherapy

PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity

Online download statistics by month:

Online download statistics by month: October 2023 to February 2026

	Abstract	Full	Pdf
Oct 2023	716	727	268
Nov 2023	238	239	98
Dec 2023	138	139	87
Jan 2024	115	115	74
Feb 2024	90	91	56
Mar 2024	98	100	110
Apr 2024	109	114	66
May 2024	197	198	64
Jun 2024	101	100	75
Jul 2024	83	83	44
Aug 2024	96	93	59
Sep 2024	107	111	67
Oct 2024	89	89	61
Nov 2024	111	112	60
Dec 2024	194	196	87
Jan 2025	109	109	58
Feb 2025	143	143	46
Mar 2025	78	78	62
Apr 2025	81	81	52
May 2025	73	74	55
Jun 2025	38	39	69
Jul 2025	1	1	0
Sep 2025	1	1	1
Feb 2026	1	1	0
Total	3007	3034	1619